APA (7th ed.) Citation

RD, L., A, S., R, R., DJ, G., M, B., F, D., . . . MG, W. (2024). Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study. Inflammatory bowel diseases, 30(10), 1714. https://doi.org/10.1093/ibd/izad248

Chicago Style (17th ed.) Citation

RD, Little, et al. "Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study." Inflammatory Bowel Diseases 30, no. 10 (2024): 1714. https://doi.org/10.1093/ibd/izad248.

MLA (9th ed.) Citation

RD, Little, et al. "Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study." Inflammatory Bowel Diseases, vol. 30, no. 10, 2024, p. 1714, https://doi.org/10.1093/ibd/izad248.